Peripheral Neuropathy Clinical Trial
Official title:
A Randomized, Four-Arm Study Comparing Reiki, Yoga, Meditation, or Patient Education Group for Addressing Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
The purpose of this study is to test whether people with symptoms of chemotherapy-induced peripheral neuropathy (CIPN) receive physical or psychological benefits from participating in a six-week Reiki, Yoga, Meditation, or Educational experience.
Chemotherapy-induced peripheral neuropathy (CIPN) is a side effect that occurs with many of
the most common chemotherapeutic agents used to treat cancer. Typically, CIPN is experienced
as tingling, burning, numbness, or pain in the upper and lower extremities and other parts
of the body. Severity of symptoms can range from bothersome to disabling and can have
profoundly negative effects on quality of life. Although the specific incidence or
prevalence of CIPN is unknown, it is generally estimated at 30 to 40 percent in patients who
have received the classes of chemotherapeutic agents used to treat breast, colon, and lung,
cancers, and lymphomas. There are no treatments or drugs that consistently ameliorate or
lead to the reversal of CIPN symptoms.Typically, symptoms of CIPN are considered along with
other pain symptoms and treated with opioids and analgesics. Additionally, the prescription
of anticonvulsant medications and tricyclic antidepressants can help alleviate neuropathic
pain. While these strategies can provide relief from cancer-related pain, they often yield
limited results for symptoms of CIPN. With few allopathic treatment alternatives for
attenuating the symptoms of CIPN, people living with these symptoms have few options other
than to endure them.
Unlike treatments based upon nociceptive and neuropathic models of pain that regard the pain
response as the outcome of a finite and mechanistic chain of biochemical events,
complementary treatments acknowledge the interpenetrating nature of the relationships
between body, mind, and spirit. Typically, complementary or integrative health strategies
incorporate psychological, emotional, and spiritual elements along with biochemical
strategies when addressing pain. Of particular interest in the proposed pilot study are
complementary techniques that include Yoga, Meditation, and Reiki.
Utilizing a pretest-posttest control group design with random assignment, this four-arm
experimental pilot study will be undertaken to determine the feasibility of three
complementary approaches in reducing the signs and symptoms of CIPN. This design was chosen
for its ability to support causal inference while managing threats to internal and external
design validity. The use of random assignment in the development of intervention and
comparison groups will strengthen the ability of this design to manage threats to internal
validity more efficiently. This pilot study involves the collection of quantitative data
from self-administered instruments that have been designed to measure health related quality
of life, symptoms of neurotoxicity, psychological distress, and mindfulness.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05152368 -
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy
|
Phase 1 | |
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Completed |
NCT02549534 -
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
|
N/A | |
Active, not recruiting |
NCT02701075 -
MC5-A Scrambler Therapy for the Treatment of Chronic Neuropathic Extremity Pain
|
N/A | |
Completed |
NCT01196442 -
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
|
N/A | |
Completed |
NCT00763087 -
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
|
N/A | |
Completed |
NCT00079807 -
Painful HIV Neuropathy and Alpha-Lipoic Acid
|
Phase 1/Phase 2 | |
Completed |
NCT03292328 -
Yoga for Symptoms of Nerve Damage Caused by Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05379140 -
Use Therapeutic Chinese Massage to Treat Peripheral Neuropathy in People With HIV
|
N/A | |
Recruiting |
NCT05673746 -
Acupuncture in Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer
|
N/A | |
Completed |
NCT05189535 -
"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"
|
Phase 2/Phase 3 | |
Recruiting |
NCT06219590 -
Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy
|
N/A | |
Enrolling by invitation |
NCT05595109 -
Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients
|
Phase 2/Phase 3 | |
Completed |
NCT05916118 -
Exercise and Oxaliplatin-induced Peripheral Neuropathy
|
N/A | |
Withdrawn |
NCT03881748 -
Clinical Trial of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Not yet recruiting |
NCT03112057 -
Visualize Nociceptor Changes in Neuropathic Human
|
N/A | |
Completed |
NCT02936843 -
Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy
|
Phase 2/Phase 3 | |
Terminated |
NCT01458015 -
Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic Pain
|
Phase 4 | |
Completed |
NCT01006408 -
Treatment Trial Using Low Level Laser Therapy (LLLT) for Treatment of Chemotherapy Induced Peripheral Neuropathy
|
N/A | |
Completed |
NCT00471445 -
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
|
Phase 3 |